New Horizon Health, a Chinese company that primarily develops cancer detection and screening products, unveiled on Friday that it has secured US$66 million in a series C round of financing led by Hong Kong-based private equity firm VMS Investment Group.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
